Topic
Philippines
Bio-Thera, Dr Reddy’s in agreement for biosimilar drugs in SE Asia
Under the agreement, Bio-Thera will maintain responsibility for the development, manufacturing, and supply of BAT2206 and BAT2506 Bio-Thera Solutions a…
Venus Remedies secures marketing authorisations for oncology drugs from Morocco, Philippines
The approvals include bortezomib in the Philippines and carboplatin in Morocco Venus Remedies has secured marketing authorizations for two key…
Lupin, Fuji in agreement for commercialisation of Nextstellis in Vietnam and Philippines
Nextstellis is a novel combination medication comprising drospirenone (DRSP) and estetrol (E4), indicated for use by women of reproductive age…
Philippines opens doors for Indian medical aspirants
Indian students who complete their Doctor of Medicine degree from a Philippine College of Medicine, will be eligible to register…
Venus Remedies bags marketing approvals from Philippines, Saudi Arabia for three drugs
While Saudi Arabia is the largest pharmaceutical market in GCC region, Philippines happens to be the second largest market in…
Venus Remedies gets marketing approval for six chemotherapy drugs from the Philippines
Venus Remedies’ oncology wing has also secured marketing authorisation from Myanmar for another chemotherapy drug Venus Remedies has received marketing…
Old NMC circular adversely affects students pursuing MD in the Philippines: Protesting parents
According to the parents, unjust NMC Circular of March 25, 2022, with retrospective effect has caused grave injustice to the…
Venus Remedies secures marketing authorisation for key cancer drugs from Philippines, Paraguay, Georgia and Moldova
The company has secured 506 marketing approvals for its oncology products across 76 countries Building upon its sizeable global presence in…
Venus Remedies bags marketing approval from the Philippines, Iraq for onco drugs
The company expects marketing authorisation from Iraq for another commonly prescribed cancer drug, gemcitabine, to enhance its reach in MENA region…
Lupin, DKSH sign exclusive licensing and supply agreement
To market five biosimilar candidates in the Philippines Lupin has signed an exclusive license and supply agreement with DKSH to…